Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen

by Jager, N. G. L., Rosing, H., Linn, S. C., Schellens, J. H. M., Beijnen, J. H.
Published 2012

Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice

by Oostendorp, Roos L., Buckle, T., Lambert, G., Garrigue, J. S., Beijnen, J. H., Schellens, J. H. M., van Tellingen, O.
Published 2010

Evaluation of α2-Integrin Expression as a Biomarker for Tumor Growth Inhibition for the Investigational Integrin Inhibitor E7820 in Preclinical and Clinical Studies

by Keizer, Ron J., Funahashi, Y., Semba, T., Wanders, J., Beijnen, J. H., Schellens, J. H. M., Huitema, A. D. R.
Published 2011

Essential medicines for breast cancer in low and middle income countries

by Bazargani, Y. T., de Boer, A., Schellens, J. H. M., Leufkens, H. G. M., Mantel-Teeuwisse, Aukje K.
Published 2015

Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment

by de Vries Schultink, A. H. M., Suleiman, A. A., Schellens, J. H. M., Beijnen, J. H., Huitema, A. D. R.
Published 2016

Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer

by Kordes, S., Klümpen, H. J., Weterman, M. J., Schellens, J. H. M., Richel, D. J., Wilmink, J. W.
Published 2015

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

by Meulendijks, D, Dewit, L, Tomasoa, N B, van Tinteren, H, Beijnen, J H, Schellens, J H M, Cats, A
Published 2014

Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry

by Beumer, J. H., Garner, R. C., Cohen, M. B., Galbraith, S., Duncan, G. F., Griffin, T., Beijnen, J. H., Schellens, J. H. M.
Published 2007

A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer

by Molloy, T J, Devriese, L A, Helgason, H H, Bosma, A J, Hauptmann, M, Voest, E E, Schellens, J H M, van't Veer, L J
Published 2011

Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation

by Hendrikx, J J M A, Lagas, J S, Wagenaar, E, Rosing, H, Schellens, J H M, Beijnen, J H, Schinkel, A H
Published 2014

Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection

by Kip, A. E., Rosing, H., Hillebrand, M. J. X., Blesson, S., Mengesha, B., Diro, E., Hailu, A., Schellens, J. H. M., Beijnen, J. H., Dorlo, T. P. C.
Published 2016

Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry

by Brouwers, E. E. M., Huitema, A. D. R., Bakker, E. N., Douma, J. W., Schimmel, K. J. M., van Weringh, G., de Wolf, P. J., Schellens, J. H. M., Beijnen, J. H.
Published 2007

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

by Boss, D S, Glen, H, Beijnen, J H, Keesen, M, Morrison, R, Tait, B, Copalu, W, Mazur, A, Wanders, J, O'Brien, J P, Schellens, J H M, Evans, T R J
Published 2012

Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer

by van der Noll, R., Smit, W. M., Wymenga, A. N. M., Boss, D. S., Grob, M., Huitema, A. D. R., Rosing, H., Tibben, M. M., Keessen, M., Rehorst, H., Beijnen, J. H., Schellens, J. H. M.
Published 2015

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53

by Meulendijks, D, Tomasoa, N B, Dewit, L, Smits, P H M, Bakker, R, van Velthuysen, M-L F, Rosenberg, E H, Beijnen, J H, Schellens, J H M, Cats, A
Published 2015

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours

by Lankheet, N A G, Kloth, J S L, Gadellaa-van Hooijdonk, C G M, Cirkel, G A, Mathijssen, R H J, Lolkema, M P J K, Schellens, J H M, Voest, E E, Sleijfer, S, de Jonge, M J A, Haanen, J B A G, Beijnen, J H, Huitema, A D R, Steeghs, N
Published 2014

Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours

by Kerklaan, B Milojkovic, Lolkema, M P J, Devriese, L A, Voest, E E, Nol-Boekel, A, Mergui-Roelvink, M, Langenberg, M, Mykulowycz, K, Stoebenau, J, Lane, S, Legenne, P, Wissel, P, Smith, D A, Giantonio, B J, Schellens, J H M, Witteveen, P O
Published 2015